CA2826733C - High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences - Google Patents
High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences Download PDFInfo
- Publication number
- CA2826733C CA2826733C CA2826733A CA2826733A CA2826733C CA 2826733 C CA2826733 C CA 2826733C CA 2826733 A CA2826733 A CA 2826733A CA 2826733 A CA2826733 A CA 2826733A CA 2826733 C CA2826733 C CA 2826733C
- Authority
- CA
- Canada
- Prior art keywords
- mar
- sequence
- purified
- sequences
- dna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 111
- 108090000623 proteins and genes Proteins 0.000 title claims description 128
- 230000014509 gene expression Effects 0.000 title claims description 80
- 238000001890 transfection Methods 0.000 title claims description 69
- 210000004962 mammalian cell Anatomy 0.000 title description 7
- 238000012546 transfer Methods 0.000 title description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 106
- 230000000694 effects Effects 0.000 claims abstract description 59
- 230000001965 increasing effect Effects 0.000 claims abstract description 31
- 230000014616 translation Effects 0.000 claims abstract description 29
- 239000011159 matrix material Substances 0.000 claims abstract description 23
- 210000004027 cell Anatomy 0.000 claims description 159
- 108020004414 DNA Proteins 0.000 claims description 85
- 239000002773 nucleotide Substances 0.000 claims description 63
- 125000003729 nucleotide group Chemical group 0.000 claims description 62
- 102000004169 proteins and genes Human genes 0.000 claims description 47
- 108091023040 Transcription factor Proteins 0.000 claims description 39
- 102000040945 Transcription factor Human genes 0.000 claims description 37
- 230000027455 binding Effects 0.000 claims description 36
- 150000007523 nucleic acids Chemical class 0.000 claims description 35
- 102000039446 nucleic acids Human genes 0.000 claims description 33
- 108020004707 nucleic acids Proteins 0.000 claims description 33
- 108010077544 Chromatin Proteins 0.000 claims description 32
- 210000003483 chromatin Anatomy 0.000 claims description 32
- 239000013598 vector Substances 0.000 claims description 25
- 230000000295 complement effect Effects 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 16
- 102100040731 Zinc finger protein 384 Human genes 0.000 claims description 13
- 230000008569 process Effects 0.000 claims description 12
- 102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 claims description 11
- -1 XFD3 Proteins 0.000 claims description 10
- 102000052510 DNA-Binding Proteins Human genes 0.000 claims description 7
- 101000572986 Homo sapiens POU domain, class 3, transcription factor 2 Proteins 0.000 claims description 7
- 101710096438 DNA-binding protein Proteins 0.000 claims description 6
- 102100037914 Pituitary-specific positive transcription factor 1 Human genes 0.000 claims description 6
- 101001096159 Homo sapiens Pituitary-specific positive transcription factor 1 Proteins 0.000 claims description 5
- 102100030835 AT-rich interactive domain-containing protein 5B Human genes 0.000 claims description 4
- 101710186200 CCAAT/enhancer-binding protein Proteins 0.000 claims description 4
- 102000006277 CDX2 Transcription Factor Human genes 0.000 claims description 4
- 108010083123 CDX2 Transcription Factor Proteins 0.000 claims description 4
- 101100518995 Caenorhabditis elegans pax-3 gene Proteins 0.000 claims description 4
- 102100023033 Cyclic AMP-dependent transcription factor ATF-2 Human genes 0.000 claims description 4
- 102100028092 Homeobox protein Nkx-3.1 Human genes 0.000 claims description 4
- 101000792947 Homo sapiens AT-rich interactive domain-containing protein 5B Proteins 0.000 claims description 4
- 101100380508 Homo sapiens ATF2 gene Proteins 0.000 claims description 4
- 101000578249 Homo sapiens Homeobox protein Nkx-3.1 Proteins 0.000 claims description 4
- 101000738966 Homo sapiens POU domain, class 6, transcription factor 1 Proteins 0.000 claims description 4
- 101000819074 Homo sapiens Transcription factor GATA-4 Proteins 0.000 claims description 4
- 108700042694 Lhx3 Proteins 0.000 claims description 4
- 101100518997 Mus musculus Pax3 gene Proteins 0.000 claims description 4
- 102000007354 PAX6 Transcription Factor Human genes 0.000 claims description 4
- 101150081664 PAX6 gene Proteins 0.000 claims description 4
- 102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 claims description 4
- 101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 claims description 4
- 102100037483 POU domain, class 6, transcription factor 1 Human genes 0.000 claims description 4
- 102000006289 Transcription Factor TFIIA Human genes 0.000 claims description 4
- 108010083262 Transcription Factor TFIIA Proteins 0.000 claims description 4
- 102100021380 Transcription factor GATA-4 Human genes 0.000 claims description 4
- 239000001963 growth medium Substances 0.000 claims description 4
- 101150027852 pou3f2 gene Proteins 0.000 claims description 4
- 101100281515 Arabidopsis thaliana FOX1 gene Proteins 0.000 claims description 3
- 102100037060 Forkhead box protein D3 Human genes 0.000 claims description 3
- 102100035134 Forkhead box protein J2 Human genes 0.000 claims description 3
- 102100035120 Forkhead box protein L1 Human genes 0.000 claims description 3
- 102100027581 Forkhead box protein P3 Human genes 0.000 claims description 3
- 102100027570 Forkhead box protein Q1 Human genes 0.000 claims description 3
- 102100036646 Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial Human genes 0.000 claims description 3
- 102100030087 Homeobox protein DLX-1 Human genes 0.000 claims description 3
- 101001029308 Homo sapiens Forkhead box protein D3 Proteins 0.000 claims description 3
- 101001023352 Homo sapiens Forkhead box protein L1 Proteins 0.000 claims description 3
- 101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 claims description 3
- 101000861406 Homo sapiens Forkhead box protein Q1 Proteins 0.000 claims description 3
- 101001072655 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial Proteins 0.000 claims description 3
- 101000864690 Homo sapiens Homeobox protein DLX-1 Proteins 0.000 claims description 3
- 101150054854 POU1F1 gene Proteins 0.000 claims description 3
- 108010042291 Serum Response Factor Proteins 0.000 claims description 3
- 102100022056 Serum response factor Human genes 0.000 claims description 3
- 101150051296 foxj2 gene Proteins 0.000 claims description 3
- 101150056399 slc20a1 gene Proteins 0.000 claims description 3
- 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 claims description 2
- 102100032881 DNA-binding protein SATB1 Human genes 0.000 claims 1
- 101000655234 Homo sapiens DNA-binding protein SATB1 Proteins 0.000 claims 1
- 101100456626 Homo sapiens MEF2A gene Proteins 0.000 claims 1
- 101000666382 Homo sapiens Transcription factor E2-alpha Proteins 0.000 claims 1
- 101000964718 Homo sapiens Zinc finger protein 384 Proteins 0.000 claims 1
- 101100079042 Mus musculus Myef2 gene Proteins 0.000 claims 1
- 102100021148 Myocyte-specific enhancer factor 2A Human genes 0.000 claims 1
- 102100038313 Transcription factor E2-alpha Human genes 0.000 claims 1
- 101150014102 mef-2 gene Proteins 0.000 claims 1
- 101000598002 Homo sapiens Interferon regulatory factor 1 Proteins 0.000 abstract description 106
- 102100036981 Interferon regulatory factor 1 Human genes 0.000 abstract description 106
- 210000003527 eukaryotic cell Anatomy 0.000 abstract description 12
- 238000003151 transfection method Methods 0.000 abstract description 8
- 239000012634 fragment Substances 0.000 description 75
- 241000282414 Homo sapiens Species 0.000 description 60
- 239000013612 plasmid Substances 0.000 description 60
- 210000000349 chromosome Anatomy 0.000 description 44
- 238000004458 analytical method Methods 0.000 description 35
- 108700019146 Transgenes Proteins 0.000 description 34
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 28
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 28
- 239000005090 green fluorescent protein Substances 0.000 description 27
- 241000699666 Mus <mouse, genus> Species 0.000 description 20
- 238000009826 distribution Methods 0.000 description 17
- 230000000875 corresponding effect Effects 0.000 description 15
- 230000001105 regulatory effect Effects 0.000 description 15
- 239000003623 enhancer Substances 0.000 description 13
- 210000000299 nuclear matrix Anatomy 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 12
- 102000008297 Nuclear Matrix-Associated Proteins Human genes 0.000 description 12
- 108010035916 Nuclear Matrix-Associated Proteins Proteins 0.000 description 12
- 101710146690 Zinc finger protein 384 Proteins 0.000 description 12
- 230000002759 chromosomal effect Effects 0.000 description 12
- 238000005534 hematocrit Methods 0.000 description 12
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- 238000002844 melting Methods 0.000 description 11
- 108090000394 Erythropoietin Proteins 0.000 description 10
- 102000003951 Erythropoietin Human genes 0.000 description 9
- 241000287828 Gallus gallus Species 0.000 description 9
- 108010047956 Nucleosomes Proteins 0.000 description 9
- 238000005452 bending Methods 0.000 description 9
- 229940105423 erythropoietin Drugs 0.000 description 9
- 210000001623 nucleosome Anatomy 0.000 description 9
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 9
- 238000003556 assay Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000010354 integration Effects 0.000 description 8
- 210000003292 kidney cell Anatomy 0.000 description 8
- 239000003550 marker Substances 0.000 description 8
- 230000003389 potentiating effect Effects 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 230000004568 DNA-binding Effects 0.000 description 7
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 7
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 238000003752 polymerase chain reaction Methods 0.000 description 7
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 239000013604 expression vector Substances 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 241000282693 Cercopithecidae Species 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 102000014150 Interferons Human genes 0.000 description 5
- 108010050904 Interferons Proteins 0.000 description 5
- 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 5
- 241000699660 Mus musculus Species 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 5
- 238000012217 deletion Methods 0.000 description 5
- 229960003722 doxycycline Drugs 0.000 description 5
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 5
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 5
- 230000006801 homologous recombination Effects 0.000 description 5
- 238000002744 homologous recombination Methods 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 230000006698 induction Effects 0.000 description 5
- 229940079322 interferon Drugs 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 230000002103 transcriptional effect Effects 0.000 description 5
- 238000011830 transgenic mouse model Methods 0.000 description 5
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 102000034356 gene-regulatory proteins Human genes 0.000 description 4
- 108091006104 gene-regulatory proteins Proteins 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 210000003917 human chromosome Anatomy 0.000 description 4
- 238000000126 in silico method Methods 0.000 description 4
- 239000012212 insulator Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000005229 liver cell Anatomy 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000008520 organization Effects 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 230000009261 transgenic effect Effects 0.000 description 4
- 102100027893 Homeobox protein Nkx-2.1 Human genes 0.000 description 3
- 101000632178 Homo sapiens Homeobox protein Nkx-2.1 Proteins 0.000 description 3
- 101000845269 Homo sapiens Transcription termination factor 1 Proteins 0.000 description 3
- 108010052285 Membrane Proteins Proteins 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 239000012124 Opti-MEM Substances 0.000 description 3
- 108010007568 Protamines Proteins 0.000 description 3
- 102000007327 Protamines Human genes 0.000 description 3
- 108700005075 Regulator Genes Proteins 0.000 description 3
- 108700008625 Reporter Genes Proteins 0.000 description 3
- 241000283984 Rodentia Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 240000006394 Sorghum bicolor Species 0.000 description 3
- 235000007230 Sorghum bicolor Nutrition 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000022131 cell cycle Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000001687 destabilization Effects 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 229940048914 protamine Drugs 0.000 description 3
- 229950010131 puromycin Drugs 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- 241000282552 Chlorocebus aethiops Species 0.000 description 2
- 108091029523 CpG island Proteins 0.000 description 2
- 241000699800 Cricetinae Species 0.000 description 2
- 241000699802 Cricetulus griseus Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102100021519 Hemoglobin subunit beta Human genes 0.000 description 2
- 108091005904 Hemoglobin subunit beta Proteins 0.000 description 2
- 108010034791 Heterochromatin Proteins 0.000 description 2
- 108010033040 Histones Proteins 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 108090000862 Ion Channels Proteins 0.000 description 2
- 102000004310 Ion Channels Human genes 0.000 description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
- 239000012097 Lipofectamine 2000 Substances 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 102100031790 Myelin expression factor 2 Human genes 0.000 description 2
- 101710107751 Myelin expression factor 2 Proteins 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 101710172711 Structural protein Proteins 0.000 description 2
- 108091008874 T cell receptors Proteins 0.000 description 2
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 2
- 102000007537 Type II DNA Topoisomerases Human genes 0.000 description 2
- 108010046308 Type II DNA Topoisomerases Proteins 0.000 description 2
- 244000000188 Vaccinium ovalifolium Species 0.000 description 2
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 208000019065 cervical carcinoma Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000012761 co-transfection Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 108091008053 gene clusters Proteins 0.000 description 2
- 238000001415 gene therapy Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000004458 heterochromatin Anatomy 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 210000005265 lung cell Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229960000485 methotrexate Drugs 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 230000008488 polyadenylation Effects 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000011218 segmentation Effects 0.000 description 2
- 210000000717 sertoli cell Anatomy 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 239000013603 viral vector Substances 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 101710084907 AT-rich binding protein Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102100027211 Albumin Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 101710095342 Apolipoprotein B Proteins 0.000 description 1
- 102100040202 Apolipoprotein B-100 Human genes 0.000 description 1
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 241000713842 Avian sarcoma virus Species 0.000 description 1
- 241000701822 Bovine papillomavirus Species 0.000 description 1
- 108010014064 CCCTC-Binding Factor Proteins 0.000 description 1
- 101100297347 Caenorhabditis elegans pgl-3 gene Proteins 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 101000986346 Chironomus tentans High mobility group protein I Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 108010068426 Contractile Proteins Proteins 0.000 description 1
- 102000002585 Contractile Proteins Human genes 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 102000010831 Cytoskeletal Proteins Human genes 0.000 description 1
- 108010037414 Cytoskeletal Proteins Proteins 0.000 description 1
- 102000003844 DNA helicases Human genes 0.000 description 1
- 108090000133 DNA helicases Proteins 0.000 description 1
- 238000012270 DNA recombination Methods 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 108700020911 DNA-Binding Proteins Proteins 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 241000702421 Dependoparvovirus Species 0.000 description 1
- 241000255601 Drosophila melanogaster Species 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 101150002621 EPO gene Proteins 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 102100031690 Erythroid transcription factor Human genes 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102100039556 Galectin-4 Human genes 0.000 description 1
- 101001035782 Gallus gallus Hemoglobin subunit beta Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 241000288105 Grus Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 108010048671 Homeodomain Proteins Proteins 0.000 description 1
- 102000009331 Homeodomain Proteins Human genes 0.000 description 1
- 101001066268 Homo sapiens Erythroid transcription factor Proteins 0.000 description 1
- 101000608765 Homo sapiens Galectin-4 Proteins 0.000 description 1
- 101001054334 Homo sapiens Interferon beta Proteins 0.000 description 1
- 101000979342 Homo sapiens Nuclear factor NF-kappa-B p105 subunit Proteins 0.000 description 1
- 101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 241000701109 Human adenovirus 2 Species 0.000 description 1
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 108091029795 Intergenic region Proteins 0.000 description 1
- 108020003631 Kinetoplast DNA Proteins 0.000 description 1
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
- 102000055120 MEF2 Transcription Factors Human genes 0.000 description 1
- 108010018650 MEF2 Transcription Factors Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 102000006890 Methyl-CpG-Binding Protein 2 Human genes 0.000 description 1
- 108010072388 Methyl-CpG-Binding Protein 2 Proteins 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000008763 Neurofilament Proteins Human genes 0.000 description 1
- 108010088373 Neurofilament Proteins Proteins 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 102100023050 Nuclear factor NF-kappa-B p105 subunit Human genes 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 102000016978 Orphan receptors Human genes 0.000 description 1
- 108070000031 Orphan receptors Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 101710129981 Pituitary-specific positive transcription factor 1 Proteins 0.000 description 1
- 241001505332 Polyomavirus sp. Species 0.000 description 1
- 108010013381 Porins Proteins 0.000 description 1
- 102000017033 Porins Human genes 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102000052575 Proto-Oncogene Human genes 0.000 description 1
- 108700020978 Proto-Oncogene Proteins 0.000 description 1
- 101000945964 Rattus norvegicus CCAAT/enhancer-binding protein beta Proteins 0.000 description 1
- 101000924396 Rattus norvegicus Cytosol aminopeptidase Proteins 0.000 description 1
- 101001001280 Rattus norvegicus Lysosomal acid phosphatase Proteins 0.000 description 1
- 101100346194 Rattus norvegicus Mpc1 gene Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 101150032199 Rplp0 gene Proteins 0.000 description 1
- 101000884545 Schizosaccharomyces pombe (strain 972 / ATCC 24843) Pre-mRNA-splicing factor cdc5 Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 208000002903 Thalassemia Diseases 0.000 description 1
- 101710183280 Topoisomerase Proteins 0.000 description 1
- 102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 description 1
- 102100027671 Transcriptional repressor CTCF Human genes 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003281 allosteric effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000019113 chromatin silencing Effects 0.000 description 1
- 238000011098 chromatofocusing Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- MKZGVLPHKXXSSG-UHFFFAOYSA-N ethyl n-[4-[benzyl(2-phenylethyl)amino]-2-[4-(trifluoromethyl)phenyl]-1h-imidazo[4,5-c]pyridin-6-yl]carbamate Chemical compound N=1C(NC(=O)OCC)=CC=2NC(C=3C=CC(=CC=3)C(F)(F)F)=NC=2C=1N(CC=1C=CC=CC=1)CCC1=CC=CC=C1 MKZGVLPHKXXSSG-UHFFFAOYSA-N 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000006195 histone acetylation Effects 0.000 description 1
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
- 229940097277 hygromycin b Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 210000005044 neurofilament Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 210000004492 nuclear pore Anatomy 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000002888 pairwise sequence alignment Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000001322 periplasm Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 210000004986 primary T-cell Anatomy 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000007056 sickle cell anemia Diseases 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 108020001568 subdomains Proteins 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 239000012096 transfection reagent Substances 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 102000027257 transmembrane receptors Human genes 0.000 description 1
- 108091008578 transmembrane receptors Proteins 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2884687A CA2884687C (en) | 2003-10-24 | 2004-10-22 | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
| CA2884685A CA2884685C (en) | 2003-10-24 | 2004-10-22 | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51357403P | 2003-10-24 | 2003-10-24 | |
| US60/513,574 | 2003-10-24 | ||
| EP04002722.9 | 2004-02-06 | ||
| EP04002722 | 2004-02-06 | ||
| CA2535836A CA2535836C (en) | 2003-10-24 | 2004-10-22 | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2535836A Division CA2535836C (en) | 2003-10-24 | 2004-10-22 | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2884685A Division CA2884685C (en) | 2003-10-24 | 2004-10-22 | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
| CA2884687A Division CA2884687C (en) | 2003-10-24 | 2004-10-22 | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2826733A1 CA2826733A1 (en) | 2005-05-06 |
| CA2826733C true CA2826733C (en) | 2016-07-12 |
Family
ID=46149058
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2826733A Expired - Lifetime CA2826733C (en) | 2003-10-24 | 2004-10-22 | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
| CA2884685A Expired - Fee Related CA2884685C (en) | 2003-10-24 | 2004-10-22 | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
| CA2884687A Expired - Lifetime CA2884687C (en) | 2003-10-24 | 2004-10-22 | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2884685A Expired - Fee Related CA2884685C (en) | 2003-10-24 | 2004-10-22 | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
| CA2884687A Expired - Lifetime CA2884687C (en) | 2003-10-24 | 2004-10-22 | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences |
Country Status (7)
| Country | Link |
|---|---|
| KR (1) | KR20120069776A (da) |
| CA (3) | CA2826733C (da) |
| DK (4) | DK2292754T3 (da) |
| ES (4) | ES2383006T3 (da) |
| PT (4) | PT2292754E (da) |
| SG (3) | SG195562A1 (da) |
| SI (4) | SI2287302T1 (da) |
-
2004
- 2004-10-22 DK DK10178871.9T patent/DK2292754T3/da active
- 2004-10-22 SI SI200432011T patent/SI2287302T1/sl unknown
- 2004-10-22 SG SG2013076948A patent/SG195562A1/en unknown
- 2004-10-22 ES ES08153753T patent/ES2383006T3/es not_active Expired - Lifetime
- 2004-10-22 SI SI200431878T patent/SI1959011T1/sl unknown
- 2004-10-22 ES ES10178871T patent/ES2399878T3/es not_active Expired - Lifetime
- 2004-10-22 ES ES10178873T patent/ES2400296T3/es not_active Expired - Lifetime
- 2004-10-22 DK DK08153753.2T patent/DK1959011T3/da active
- 2004-10-22 SI SI200432010T patent/SI2292754T1/sl unknown
- 2004-10-22 PT PT10178871T patent/PT2292754E/pt unknown
- 2004-10-22 SG SG10201500656RA patent/SG10201500656RA/en unknown
- 2004-10-22 DK DK10178873.5T patent/DK2298898T3/da active
- 2004-10-22 PT PT10178873T patent/PT2298898E/pt unknown
- 2004-10-22 CA CA2826733A patent/CA2826733C/en not_active Expired - Lifetime
- 2004-10-22 PT PT08153753T patent/PT1959011E/pt unknown
- 2004-10-22 SG SG10201500657PA patent/SG10201500657PA/en unknown
- 2004-10-22 CA CA2884685A patent/CA2884685C/en not_active Expired - Fee Related
- 2004-10-22 PT PT10178866T patent/PT2287302E/pt unknown
- 2004-10-22 KR KR1020127012896A patent/KR20120069776A/ko not_active Withdrawn
- 2004-10-22 SI SI200432012T patent/SI2298898T1/sl unknown
- 2004-10-22 ES ES10178866T patent/ES2399877T3/es not_active Expired - Lifetime
- 2004-10-22 CA CA2884687A patent/CA2884687C/en not_active Expired - Lifetime
- 2004-10-22 DK DK10178866.9T patent/DK2287302T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2884685A1 (en) | 2005-05-06 |
| DK2298898T3 (da) | 2013-04-08 |
| PT2292754E (pt) | 2013-03-11 |
| CA2826733A1 (en) | 2005-05-06 |
| SG195562A1 (en) | 2013-12-30 |
| ES2383006T3 (es) | 2012-06-15 |
| DK1959011T3 (da) | 2012-07-02 |
| SI1959011T1 (sl) | 2012-06-29 |
| DK2287302T3 (da) | 2013-04-08 |
| SI2287302T1 (sl) | 2013-04-30 |
| KR20120069776A (ko) | 2012-06-28 |
| CA2884687A1 (en) | 2005-05-06 |
| PT2287302E (pt) | 2013-03-11 |
| ES2399878T3 (es) | 2013-04-04 |
| SG10201500656RA (en) | 2015-04-29 |
| PT2298898E (pt) | 2013-03-11 |
| ES2400296T3 (es) | 2013-04-08 |
| SG10201500657PA (en) | 2015-04-29 |
| PT1959011E (pt) | 2012-05-25 |
| CA2884685C (en) | 2016-12-20 |
| SI2298898T1 (sl) | 2013-04-30 |
| SI2292754T1 (sl) | 2013-04-30 |
| CA2884687C (en) | 2016-08-23 |
| ES2399877T3 (es) | 2013-04-04 |
| DK2292754T3 (da) | 2013-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10669562B2 (en) | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of MAR sequences | |
| CA2826733C (en) | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of mar sequences | |
| HK1151825B (en) | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences | |
| HK1149777B (en) | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences | |
| HK1151824B (en) | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences | |
| HK1120549B (en) | High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20140224 |